Stay updated on Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FESICcJCadYoAd6qtOUvQSBGMPzE.uncropped.jpg&w=3840&q=75)
Latest updates to the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoNo Change Detected
- Check5 days agoNo Change Detected
- Check7 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check21 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check26 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check27 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check28 days agoChange DetectedThe value 'Show more Revision: v2.9.0' has been updated to 'MedlinePlus related topics: Pancreatic Cancer, Genetic and Rare Diseases Information Center resources: Pancreatic Cancer, Drug Information available for: Nivolumab, FDA Drug and Device Resources'. This change reflects additional information related to resources and drug availability for the treatment of pancreatic cancer.SummaryDifference17%
- Check32 days agoChange DetectedThe value of the revision has been updated from v2.8.1 to v2.9.0, indicating a recent change in the version of the webpage content.SummaryDifference2%
Stay in the know with updates to Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.